Clinical Trials
84
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (57 trials with phase data)• Click on a phase to view related trials
PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell Lymphoma
- First Posted Date
- 2025-10-06
- Last Posted Date
- 2025-10-06
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 56
- Registration Number
- NCT07207785
- Locations
- 🇮🇹
IRCCS Istituto Romagnolo per lo studio dei Tumori "Dino Amadori" - IRST S.R.L. - Ematologia, Meldola, Forlì-Cesena, Italy
🇮🇹Istituto Clinico Humanitas - U.O. Ematologia, Rozzano, Milano, Italy
🇮🇹AOU Ospedali Riuniti - Clinica di Ematologia, Ancona, Italy
Long-term Assessment of Chlormethine Gel in Mycosis Fungoides
- Conditions
- Cutaneous T-Cell Lymphoma/Mycosis Fungoides
- First Posted Date
- 2025-07-01
- Last Posted Date
- 2025-07-04
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 190
- Registration Number
- NCT07046663
- Locations
- 🇮🇹
AOU Ospedali Riuniti - Clinica di Ematologia, Ancona, Italy
🇮🇹SC Dermatologia, ASST-Papa Giovanni XXIII,, Bergamo, Italy
🇮🇹UO Dermatologia - IRCCS Policlinico S.Orsola-Malpighi, Bologna, Italy
A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated With a Simplified Geriatric Assessment (sGA): a Phase II Study of the Fondazione Italiana Linfomi (FIL)
- Conditions
- Diffuse Large B Cell Non-Hodgkin Lymphoma
- Interventions
- Drug: Rituximab + Golcadomide (CC-99282)
- First Posted Date
- 2025-02-19
- Last Posted Date
- 2025-08-12
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 47
- Registration Number
- NCT06835530
- Locations
- 🇮🇹
AOU SS. Antonio e Biagio e Cesare Arrigo di Alessandria - SCDU Ematologia, Alessandria, Italy
🇮🇹AOU Ospedali Riuniti - Clinica di Ematologia, Ancona, Italy
🇮🇹Azienda Ospedaliera S. Giuseppe Moscati - S.C. Ematologia e trapianto emopoietico, Avellino, Italy
Study on Plasmablastic Lymphoma Patients
- Conditions
- Plasmablastic Lymphoma
- First Posted Date
- 2025-01-17
- Last Posted Date
- 2025-05-30
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 200
- Registration Number
- NCT06781359
- Locations
- 🇮🇹
IRCCS Centro di Riferimento Oncologico di Aviano, Divisione di Oncologia e dei Tumori immuno-correlati, Aviano, PN, Italy
🇮🇹Ospedale C.e G. Mazzoni, U.O.C. di Ematologia, Ascoli Piceno, Italy
🇮🇹ASST Spedali Civili di Brescia, Ematologia, Brescia, Italy
Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma
- Conditions
- Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-09-11
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 200
- Registration Number
- NCT06588205
- Locations
- 🇮🇹
AUSL Modena sede di Sassuolo - UOSD di Oncologia Area Sud, Sassuolo, Italy
🇮🇹A.O.U. SS. Antonio e Biagio e C. Arrigo - S.C.D.U. Ematologia, Alessandria, Italy
🇮🇹A.O.U. Ospedali Riuniti delle Marche - Clinica di Ematologia, Ancona, Italy
- Prev
- 1
- 2
- 3
- 4
- 5
- 17
- Next